The present work uncovered a novel mechanism of the tumor suppression by DRAM1: promoting EGFR endosomal-lysosomal trafficking and degradation in NSCLC in vitro and in vivo through interacting with EPS15 and promoting the assembly of lysosomal v-ATPase (Fig. 7). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.